Stephen Wargacki - 01 Jan 2023 Form 3 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
SVP, Research & Development
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
3
Filing time
11 Jan 2023, 15:05:20 UTC
Next filing
09 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AQST Common Stock 26,956 01 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AQST Non-Qualified Stock Option (right to buy) 01 Jan 2023 Common Stock 15,000 $3.84 Direct F2
holding AQST Non-Qualified Stock Option (right to buy) 01 Jan 2023 Common Stock 21,000 $5.69 Direct F3
holding AQST Non-Qualified Stock Option (right to buy) 01 Jan 2023 Common Stock 12,500 $6.62 Direct F4
holding AQST Non-Qualified Stock Option (right to buy) 01 Jan 2023 Common Stock 25,000 $4.07 Direct F5
holding AQST Non-Qualified Stock Option (right to buy) 01 Jan 2023 Common Stock 25,000 $0.8800 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 20,000 restricted stock units ("RSUs"), which are scheduled to vest as follows: 5,000 on March 10, 2023, 5,000 on March 10, 2024; and 10,000 on March 10, 2025.
F2 Grant of non-qualified stock options, of which 25% vested on August 9, 2020, 25% vested on August 9, 2021, and 50% vested on August 9, 2022.
F3 Grant of non-qualified stock options, of which 25% vested on May 12, 2021, 25% vested on May 12, 2022, and 50% are scheduled to vest on May 12, 2023.
F4 Grant of non-qualified stock options, of which 25% vested on November 24, 2021, 25% vested on November 24, 2022, and 50% are scheduled to vest on November 24, 2023.
F5 Grant of non-qualified stock options, of which 25% vested on June 10, 2022, 25% are scheduled to vest on June 10, 2023, and 50% are scheduled to vest on June 10, 2024.
F6 Grant of non-qualified stock options, which is scheduled to vest as follows: 25% on August 5, 2023, 25% on August 5, 2024, and 50% on August 5, 2025.

Remarks:

Exhibit List Exhibit 24 -- Power of Attorney